![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences to Present at Sidoti & Company 2011 Micro-Cap Conference
December 16, 2010 09:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Dec. 16, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that Richard A. Franco, Chief Executive Officer and President, is scheduled to present at the...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences KRN5500 Reduces Allodynia in Patients With Neuropathic Pain
December 14, 2010 09:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Dec. 14, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today additional positive results from its successfully completed KRN5500 Phase 2a Clinical Study for...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences to Present at the 14th Annual Biotech & Specialty Pharmaceuticals Industry Investor Conference of the New York Society of Security Analysts ("NYSSA")
November 15, 2010 09:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Nov. 15, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a biopharmaceutical development company, today announced that the Company will present at the New York Society of...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
NASDAQ Grants DARA's Request for Continued Listing
November 11, 2010 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Nov. 11, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) today announced that a NASDAQ Listing Qualifications Panel (the "Panel") has granted the Company's request for an...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Announces Successful Completion of a Phase I Clinical Study of DB959 for the Treatment of Type 2 Diabetes
November 04, 2010 08:30 ET
|
DARA BioSciences, Inc.
DB959 is a Highly Selective, Non-TZD
First-In-Class Dual PPAR-Delta/Gamma Agonist
DARA is Advancing Two Drugs From Its Portfolio Through Clinical Trials
RALEIGH, N.C., Nov. 4, 2010 (GLOBE...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Awarded Grants Totaling Approximately $500,000 for Its Two Drugs Advancing Through Clinical Studies
November 02, 2010 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Nov. 2, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences (Nasdaq:DARA) announced today grant approvals by the Internal Revenue Service under the Patient Protection and Affordable Care Act of...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Signs Definitive Agreement to Raise $1.4 Million in Registered Direct Offering
October 25, 2010 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Oct. 25, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA Announces Analytical Results in Efficacy and Dose Response of KRN5500 in Patients with Chemotherapy Induced Peripheral Neuropathy and Advanced Cancer
September 08, 2010 10:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 8, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences (Nasdaq:DARA) announced today that it presented study results from its Phase 2 multicenter, placebo controlled, double-blind,...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences to Present at Rodman & Renshaw Annual Global Investment Conference
September 01, 2010 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 1, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that Richard A. Franco, R.Ph., Chief Executive Officer and President, is scheduled to present at...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Selected to Present at the 13th World Congress on Pain
August 20, 2010 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Aug. 20, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that the company has been selected by the Scientific Program Committee to present at the Congress...